Fluconazole: Clinical Trials

209 trials of Fluconazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

156 completed, 19 unknown, 12 recruiting, 9 terminated. 58 Phase 1, 52 Phase 3, 37 Not applicable, 35 Phase 2, 21 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 158Completed 50, Withdrawn 4, Not yet recruiting 2, Active not recruiting 1, Terminated 1
Phase 352Completed 34, Unknown 6, Terminated 5, Recruiting 4, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1
Not applicable37Completed 30, Unknown 4, Recruiting 3
Phase 235Completed 26, Terminated 3, Unknown 3, Recruiting 2, Withdrawn 1
Phase 421Completed 12, Recruiting 4, Unknown 3, Terminated 1, Withdrawn 1
Early Phase 13Active not recruiting 1, Completed 1, Not yet recruiting 1

Follow Fluconazole: new trials by email Literature Review of Fluconazole trials Research Report on Fluconazole

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers
Immediate ART Initiation, Delayed ART Initiation, 10-Week Fluconazole - Cryptococcal Antigenemia, HIV-1-infection
Phase 3Not yet recruitingUniversity of Minnesota5052027-01-052026-09-03
A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
Clifutinib, Itraconazole, fluconazole - Healthy Adult Subject
Phase 1Not yet recruitingSunshine Lake Pharma Co., Ltd.802026-12-312026-04-27
Drug-Drug Interactions of JMKX003142 in Healthy Participants
JMKX003142 tablets, Fluconazole Capsules, Cocktail Substrates (Midazolam Oral Solution, Rosuvastatin Calcium Tablets, and Digoxin Tablets) - ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Phase 1Not yet recruitingJemincare1122026-05-112026-05-04
The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study
Vaginal lactoferrin, Usual care - Bacterial Vaginosis, Candida Vaginal
Not applicableRecruitingGuy's and St Thomas' NHS Foundation Trust1142026-04-162026-05-29
A Study of Olomorasib (LY3537982) in Healthy Participants
Olomorasib, Fluconazole - Healthy
Phase 1CompletedEli Lilly and Company152026-03-022026-05-19
A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults
Setidegrasib, Fluconazole, Carbamazepine - Healthy Volunteer
Phase 1Active not recruitingAstellas Pharma Global Development, Inc.542026-02-032026-08-27
Effect of Antifungals on the Intestinal Microbiome - a Randomized, Controlled, Proof-of-concept Trial
Fluconazole 200mg tab - Gut Microbiome, Healthy Adult Male
Early Phase 1Not yet recruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)502026-01-012025-12-19
Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis
Itraconazole (200 mg), Fluconazole 150 mg - Tinea Corporis, Dermatophytosis
Phase 4RecruitingUrooj Fatima1262025-11-012026-01-15
The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting
Placebo, Fluconazole 150 mg - Cardiovascular
Not applicableRecruitingUniversité de Sherbrooke402025-11-012026-04-13
Rezafungin Prophylaxis in Liver Transplant
Rezafungin, Standard of care antifungal prophylaxis - Liver Transplant Infection, Fungal Infection
Phase 3Enrolling by invitationFernanda P Silveira, MD, MS3852025-10-152026-09-29
A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144
PF-07248144, Fluconazole - Healthy Adults
Phase 1CompletedPfizer122025-08-262026-06-09
Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor
Fluconazole, Itraconazole - Pityriasis Versicolor
Phase 4RecruitingKhyber Teaching Hospital1062025-03-012025-04-10
A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.
EDP-323, Itraconazole, carbamazepine - RSV Infection, Drug Drug Interaction (DDI)
Phase 1CompletedEnanta Pharmaceuticals, Inc482025-01-272025-07-01
A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients
WXSH0102/placebo, fluconazole capsules/placebo - Vaginitis
Phase 2RecruitingCisen Pharmaceutical CO., LTD.1082025-01-132025-02-13
Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis
Pivmecillinam, Amoxicillin clavulanic acid, Amoxicillin - Cystectomy, Bladder Cancer Requiring Cystectomy
Phase 4RecruitingCopenhagen University Hospital, Rigshospitalet2482025-01-072025-01-09
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
Fosmanogepix, Caspofungin, Fluconazole - Candidemia, Candidiasis, Invasive
Phase 3RecruitingBasilea Pharmaceutica4502024-12-112026-10-19
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
Fluconazole, Placebo, IL-23 Therapy - Crohn's Disease, Inflammatory Bowel Diseases
Phase 3RecruitingWeill Medical College of Cornell University1202024-10-042026-08-20
Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial.
Intralesional triamcinolone acetonide and fluconazole, Topical mometasone furoate and miconazole nitrate, Elica-M® - Chronic Paronychia
Phase 3Active not recruitingCairo University212024-08-172025-12-31
Introduction of Mycotic Prophylaxis At Cystectomy Trial.
Fluconazole, Isotonic saline solution - Cystectomy
Phase 4RecruitingCopenhagen University Hospital, Rigshospitalet4202024-06-242026-08-12
A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants
LY4100511 (DC-853), Itraconazole, Fluconazole - Healthy
Phase 1CompletedDICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company502024-04-032025-04-27

Showing 20 of 209. Sign in to see all of them.

Conditions studied

HIV Infections (39)  ·  Acquired Immunodeficiency Syndrome (33)  ·  Meningitis, Cryptococcal (27)  ·  Mycoses (26)  ·  Candidiasis (23)  ·  AIDS-Related Opportunistic Infections (22)  ·  Candidiasis, Vulvovaginal (21)  ·  Cryptococcosis (18)  ·  Meningitis (18)  ·  Candidemia (13)  ·  Candidiasis, Invasive (12)  ·  Candidiasis, Oral (8)  ·  AIDS-Related Complex (6)  ·  Fungemia (6)  ·  Invasive Fungal Infections (6)

Sponsors

Pfizer (33)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (15)  ·  Scynexis, Inc. (5)  ·  University of Minnesota (5)  ·  Boehringer Ingelheim (4)  ·  Jiangsu HengRui Medicine Co., Ltd. (4)  ·  Astellas Pharma Inc (3)  ·  Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (3)  ·  Eli Lilly and Company (3)  ·  Enanta Pharmaceuticals, Inc (3)  ·  ANRS, Emerging Infectious Diseases (2)  ·  Alexion Pharmaceuticals, Inc. (2)  ·  Bristol-Myers Squibb (2)  ·  Cairo University (2)  ·  Children's Oncology Group (2)

Countries

United States (103)  ·  Canada (18)  ·  China (17)  ·  Belgium (12)  ·  Italy (12)  ·  France (11)  ·  Germany (11)  ·  Spain (11)  ·  United Kingdom (10)  ·  South Korea (9)  ·  Greece (6)  ·  Netherlands (6)  ·  Thailand (6)  ·  Uganda (6)  ·  Israel (5)

Top investigators

David Angulo, MD (4)  ·  Radha Rajasingham, MD (3)  ·  Armstrong D (2)  ·  Gaetano Morelli, MD (2)  ·  Lindsey Albenberg, DO (2)  ·  Richard Brundage, PhD (2)  ·  Shangrong Fan, M.D. (2)  ·  William Dismukes (2)  ·  A Stewart (1)  ·  A-Dong Shen, Master (1)  ·  Adam Reich, MD, PhD (1)

Results publications

PMID 28459966, PMID 28597967, PMID 31280481, PMID 33438477, PMID 33891293, PMID 36396498, PMID 38008099, PMID 38502709, PMID 39468640, PMID 39529079, PMID 41940006, PMID 14964746, PMID 15470330, PMID 16505648, PMID 17568028, PMID 17651612, PMID 18840077, PMID 19144094, PMID 19172247, PMID 19441980, PMID 19734776, PMID 19897055, PMID 19915602, PMID 19968146, PMID 20415574, PMID 20826719, PMID 20881067, PMID 21555712, PMID 22463890, PMID 22565425, PMID 22606232, PMID 22895351, PMID 23150682, PMID 23303450, PMID 23373662, PMID 23525432, PMID 23924680, PMID 23943184, PMID 23959319, PMID 24009246, PMID 24079585, PMID 24298851, PMID 24352873, PMID 24559321, PMID 24655871, PMID 24675657, PMID 24794367, PMID 24824900, PMID 24918945, PMID 24925526

NIH funding

2008 (3), 2017 (2), U10CA095861 (2), UG1CA189955 (2), 2014 (1), 2015 (1), 2018 (1), 2023 (1), 2025 (1), K23DK109136 (1), P01GM032165 (1), P30MH075673 (1), P50GM060338 (1), R01GM069753 (1), R01HD057956 (1)